This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Revvity Past Earnings Performance
Past criteria checks 0/6
Revvity's earnings have been declining at an average annual rate of -31.7%, while the Life Sciences industry saw earnings growing at 9.1% annually. Revenues have been declining at an average rate of 8% per year. Revvity's return on equity is 3.2%, and it has net margins of 8.3%.
Key information
-31.70%
Earnings growth rate
-33.81%
EPS growth rate
Life Sciences Industry Growth
26.83%
Revenue growth rate
-7.98%
Return on equity
3.15%
Net Margin
8.26%
Last Earnings Update
28 Sep 2025
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Revvity makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
BIT:1RVTY Revenue, expenses and earnings (USD Millions)
Date
Revenue
Earnings
G+A Expenses
R&D Expenses
28 Sep 25
2,813
232
928
209
29 Jun 25
2,798
279
936
207
30 Mar 25
2,770
296
939
201
29 Dec 24
2,755
283
931
197
29 Sep 24
2,722
258
949
199
30 Jun 24
2,708
197
942
202
31 Mar 24
2,726
183
943
211
31 Dec 23
2,751
180
942
217
01 Oct 23
2,796
213
898
222
02 Jul 23
2,837
250
903
222
02 Apr 23
3,024
353
918
221
01 Jan 23
3,312
513
940
222
02 Oct 22
3,599
599
1,001
222
03 Jul 22
3,748
637
989
219
03 Apr 22
3,483
694
885
195
02 Jan 22
3,828
889
854
200
03 Oct 21
4,155
1,086
893
197
04 Jul 21
4,257
1,155
893
197
04 Apr 21
4,438
1,074
961
217
03 Jan 21
2,663
631
729
146
04 Oct 20
3,234
412
887
196
05 Jul 20
2,977
294
866
191
05 Apr 20
2,887
226
845
190
29 Dec 19
2,884
228
833
189
29 Sep 19
2,835
235
806
194
30 Jun 19
2,802
251
794
197
31 Mar 19
2,783
247
790
196
30 Dec 18
2,778
237
809
194
30 Sep 18
2,663
128
761
180
01 Jul 18
2,543
149
719
166
01 Apr 18
2,387
147
667
152
31 Dec 17
2,257
157
615
139
01 Oct 17
2,182
258
587
135
02 Jul 17
2,142
215
580
129
02 Apr 17
2,132
210
584
128
01 Jan 17
2,116
216
585
124
02 Oct 16
1,999
198
574
108
03 Jul 16
2,048
199
583
110
03 Apr 16
2,076
190
583
110
03 Jan 16
2,105
189
586
113
04 Oct 15
2,263
176
661
127
28 Jun 15
2,241
164
657
126
29 Mar 15
2,234
167
656
124
28 Dec 14
2,070
130
648
108
Quality Earnings: 1RVTY has a large one-off loss of $75.9M impacting its last 12 months of financial results to 28th September, 2025.
Growing Profit Margin: 1RVTY's current net profit margins (8.3%) are lower than last year (9.5%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 1RVTY's earnings have declined by 31.7% per year over the past 5 years.
Accelerating Growth: 1RVTY's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 1RVTY had negative earnings growth (-9.7%) over the past year, making it difficult to compare to the Life Sciences industry average (17.5%).
Return on Equity
High ROE: 1RVTY's Return on Equity (3.2%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2025/11/26 01:09
End of Day Share Price
2025/11/21 00:00
Earnings
2025/09/28
Annual Earnings
2024/12/29
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Revvity, Inc. is covered by 34 analysts. 16 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.